authentica solutions | $6,200,000 | (Jun 28, 2024)
Pear Commerce | $10,000,000 | (Jun 28, 2024)
Synthpop - Healthcare AI | $5,600,000 | (Jun 28, 2024)
Certified by Founder
Lodge
HEPHAISTOS-Pharma
start up
France
- Orsay, Île-de-France
- 17/05/2024
- Seed
- $11,189,199
HEPHAISTOS-Pharma est une startup en biotechnologie développant des immunothérapies anti-tumorales permettant de révolutionner les traitements contre le cancer en décuplant l'efficacité des anticorps monoclonaux et en permettant le traitement de tumeurs incurables.
- Industry Biotechnology
- Website https://hephaistos-pharma.fr/
- LinkedIn https://www.linkedin.com/company/hephaistos-pharma/
Related People
Frederic CAROFFFounder
France -
Boulogne-Billancourt, Île-de-France
Biotechnology entrepreneur for 10 years, I am currently the CEO of HEPHAISTOS-Pharma, a biotech company developing new immunotherapies in oncology in order to revolutionize the effectiveness of cancer treatments.
Our ONCO-Boost technology allows us to stimulate patients' immunity to treat cold tumors such as Osteosarcoma, an orphan disease, but also to increase the effectiveness of therapeutic antibodies in combination.
Supercede | The Reinsurance Platform | $15,000,000 | (Jun 28, 2024)
illumex | $13,000,000 | (Jun 28, 2024)
AuthZed | $12,000,000 | (Jun 28, 2024)
Smartworks | $12,000,000 | (Jun 28, 2024)
Synthflow AI | $7,400,000 | (Jun 28, 2024)
Odaseva | $54,000,000 | (Jun 28, 2024)
Heidi | $7,075,684 | (Jun 28, 2024)
KarmaCheck | $45,000,000 | (Jun 28, 2024)
Dodona Analytics | Undisclosed Amount | (Jun 28, 2024)
Ginossar Ventures | $13,000,000 | (Jun 28, 2024)